Authors
Lauren Biscaldi is the managing editor of Drug Topics®.
Jerry Shapiro, MD, professor of dermatology, NYU Langone Health Center.
Advertisement
Advertisement
Trending on AJMC
1
Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug
2
As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning
3
Early Secukinumab Sustains Psoriasis Clearance a Year After Stopping
4
ACO-SWITCH to Evaluate Tafamidis-to-Acoramidis Switch in ATTR-CM
5
